MESLO Egypt and North Africa for Scientific Equipment’s Post

Our very own Patrick Burke and Gloria Bae had the distinct honor of meeting with Hyundong Cho, the Korean Ambassador to the United States last week at the 2024 July KAPAL Bio-Forum Hosted by the Korean-American Professional Association of Life Sciences (KAPAL), the event brought together regional government officials and industry leaders to discuss the myriad benefits offered to foreign companies entering the US market. Held at the Embassy of the Republic of Korea, the forum highlighted the Washington DC-Maryland-Virginia (DMV) area as a strategic gateway to the US life sciences market among other topics. We are proud to be part of such impactful discussions and look forward to collaboration with foreign companies looking to explore the US Life Sciences market and assisting their growth. #LifeSciences #KAPAL #GlobalBusiness #USMarket #DMVarea #Amarex #ClinicalResearch #CRO #ClinicalTrials #Pharma #Biotech #RegulatoryAffairs #DrugDevelopment #MedicalResearch #LifeSciences #HealthcareInnovation #ClinicalOperations #ResearchAndDevelopment #Biopharma #ClinicalData #ClinicalSolutions #ClinicalDevelopment

EU 🇪🇺Botswana 🇧🇼Business Forum. A way forward for investing in the development of the Pharmaceutical Industry of Botswana and the Southern African region.

We made significant progress this quarter against our strategic priorities. ✅ Scale-up synthesis and planned regulatory-enabling studies with Flavocide on track with filing of the registration dossier with the APVMA planned for Q4 CY25 ✅Began pilot scale production of Flavocide following the appointment of a large contract manufacturing company in India ✅New patents granted in Japan and Australia for use of Flavocide ✅Bio-Gene accepted as the only Australian company member of The International Biocontrol Manufacturers Association (IBMA)   Read our latest quarterly report https://lnkd.in/gTZPM4PS #smallcaps #insectcontrol  #cropprotection #public health 

🚀 Webinar: Creating a South African Medical Cannabis Country Competitive Strategy 🌱 📅 Date: 27 August 2024 🕖 Time: 19:00 (SAST) The global medical cannabis industry is evolving, and there’s a growing debate around outdoor cultivation, the relevance of EU GMP frameworks, and Africa's role in this space. Thanks to Trenton Birch and Linda Siboto from Cheeba Africa to let us unpack and assess how South Africa can develop a winning competitive strategy in this dynamic environment. 🔊 Panelists: Rob S. (Avitas Consulting / Global Cannabis Exchange, Canada/Portugal) Zaid Mohidin (Vitacann Pharm, South Africa) Daniel Simkin Kunisch (Trade Green Consulting / Cheeba Cannabis Consulting, Spain/Germany) Edgar Adams (Medigrow, South Africa) Ayanda Bam (Texttan / Zageta Solutions, South Africa) This is a complex and evolving discussion that demands focus and analysis. At Valenveras, we believe that the integration of advanced Near-Infrared (NIR) spectroscopy through Neospectra from Si-Ware Systems, combined with our customized models, can revolutionize the cannabis industry in South Africa. 🔗 Register here: https://lnkd.in/drRHTAgK #CannabisIndustry #SouthAfrica #Webinar #Valenveras #Innovation #FutureOfCannabis

The first investment refers to INDUSTRY 5.0 approved by the European Commission. Company #Vonpharma Si, predstavništvo in prodaja, d. o. o. Location #SLOVENIA Amount EUR 5,870,871.27. The company and the products or services are in no relation to INDUSTRY 5.0 origin or principles. Details zn the next INDUSTRY 5.0 NEWSLETTER INDUSTRY 5.0 AMBASSADORS NETWORK Industry 5.0 INDUSTRY 5.0 STRATEGIC ALLIANCE

[Blog Post ] Q&A Regarding Common Concerns of China's NMPA 🌏Numerous international health-tech companies have been drawn to China's swiftly expanding pharmaceutical market. With a significant patient population and a notable prevalence of severe and chronic diseases, China holds immense potential. However, the primary obstacle hindering the entry of most foreign businesses into the Chinese market is their lack of knowledge about China's regulatory approval process. 🤔 💡The regulatory process is complex and time-consuming, with strict requirements and regional-specific documents. Recent reforms by NMPA have made it easier for international companies to enter the Chinese market. 👉Here our local experts in China answer some of the most typical questions being asked: https://lnkd.in/ePV5BrYC Linsen Du, Lei Gu (Gary), Nadine Ralph, Paul Cooper, Marjan Abdorahim, PhD, Hubert R. #ChinaNMPA #regulatoryprocess #chinaexpansion #chinesemarket

⚡New Policy Brief Alert ⚡ Africa's journey towards self-sufficiency in pharmaceutical production is a critical step in strengthening continental health security. However, achieving this goal requires a multifaceted approach, including strategic trade policies. Our new policy brief, "Do as Everyone Else: Policies and Strategies for the Growth of Africa's Pharmaceutical Sector: Lessons from South Korea, Algeria, and South Africa," explores the key trade measures that can facilitate local pharmaceutical manufacturing. Published by the GIZ African Union implemented Strengthening Crisis and Pandemic Response in Africa (SCPRA) Project and launched at African Continental Free Trade Area (AfCFTA) Secretariat Biashara Afrika 2024 in Kigali, Rwanda, this brief offers insights from successful case studies and provides actionable recommendations for policymakers. ❗❗❗ Key takeaways: 1. Trade liberalization: Reducing trade barriers can foster competition, lower costs, and encourage investment in pharmaceutical manufacturing. 2. Regional integration: Enhancing regional cooperation can create a larger market for African-made pharmaceuticals and improve supply chain efficiency. 3. Intellectual property rights: Striking a balance between protecting intellectual property and promoting innovation is essential for sustainable development. 4. Industrial policy: Targeted government support can help develop domestic pharmaceutical industries and attract foreign investment. By implementing these strategies, Africa can accelerate its progress towards a more resilient and self-sufficient pharmaceutical sector. You can read more here: https://lnkd.in/eM45eiVW #Africa #PharmaceuticalManufacturing #TradePolicy #HealthSecurity #BiasharaAfrika #GIZ Cornelius Oepen Ambassador Philip Thigo, MBS Jide Martyns Okeke, PhD Babajide Sodipo Claudia Aguirre Shingai Machingaidze Faith Nekabari Nfii Wesley Ronoh Chiluba Mwila, PhD Yvonne K. Mburu

Guideline for Post Market Quality Monitoring of Biological Products in Egypt, Version No. 1, 21-Jul-2024 The Egyptian Drug Authority (EDA) published this document to provide a comprehensive guideline for the post-market quality monitoring of biological products in Egypt. The purpose is to ensure the safety, quality, and efficacy of these products once they are available in the market. The scope of this guideline encompasses all licensed biological products in Egypt and involves collaboration between the EDA and other stakeholders. It outlines both proactive and reactive strategies for monitoring. #Biologicalproducts #EDA #Egypt #RegulatoryAffairs #vizenlifesciences

We are proud to continue leading this important platform for dialogue between Uzbekistan state authorities and European companies and organizations in the interests of better healthcare system of Uzbekistan. In addition to discussing 2024 goals of The Europe-Uzbekistan Association for Economic Cooperation — EUROUZ Healthcare & Life Sciences Committee, our partner Zafar Vakhidov has summarized updates in healthcare and pharma regulations and structure, which we constantly monitor at Vakhidov & Partners. #change #leadingtheway #healthcare #pharma #medicaldevices #medical #medicalequipment #prices #eu #lifesciences #Uzbekistan #publicprocurement #medicalinsurance #intellectualproperty #counterfeit #unfaircompetition #brandmimicking #trademarks #medicines